GRAM-NEGATIVE PERITONITIS-THE ACHILLES HEEL OF PERITONEAL DIALYSIS?SZETO, Cheuk-Chun; CHOW, Kai-Ming.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S267-S271, SUP2Conference Paper

THIAZOLIDINEDIONES IN PERITONEAL DIALYSIS PATIENTSSZETO, Cheuk-Chun; CHOW, Kai-Ming.Peritoneal dialysis international. 2009, Vol 29, Num 3, pp 248-251, issn 0896-8608, 4 p.Article

Peritoneal dialysis adequacy in Asia: Is higher better?LI, Philip K. T; SZETO, Cheuk-Chun.Peritoneal dialysis international. 2003, Vol 23, pp S65-S68, issn 0896-8608, SUP2Article

Proceedings of the ISPD 2006: proceedings of the 11th Congress of the International Society for Peritoneal Dialysis, Achieving PD Excellence, Hong Kong, August 25-August 29, 2006SZETO, Cheuk Chun; CHAN, Tak Mao.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, 313 p., SUP2Conference Proceedings

LONG-TERM PERITONEAL DIALYSIS IN INFANTSREES, Lesley.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S180-S184, SUP2Conference Paper

BODY COMPOSITION ANALYSIS TECHNIQUES IN ADULT AND PEDIATRIC PATIENTS : HOW RELIABLE ARE THEY? HOW USEFUL ARE THEY CLINICALLY?WOODROW, Graham.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S245-S249, SUP2Conference Paper

AN OVERVIEW OF THE PATHOPHYSIOLOGY OF VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASESTOMPOR, Tomasz.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S215-S222, SUP2Conference Paper

PERITONEAL DIALYSIS IN PATIENTS WITH DIABETES : ARE THE BENEFITS GREATER THAN THE DISADVANTAGES?KURIYAMA, Satoru.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S190-S195, SUP2Conference Paper

VARIOUS OBSTACLES TO PERITONEAL DIALYSIS DEVELOPMENT IN JAPAN : TOO MUCH MONEY? TOO MUCH FEAR?KAWAGUCHI, Yoshindo.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S56-S58, SUP2Conference Paper

CAN WE OVERCOME THE PREDESTINED POOR SURVIVAL OF DIABETIC PATIENTS? PERSPECTIVES FROM PRE-AND POST-DIALYSISKIM, Yong-Lim.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S171-S175, SUP2Conference Paper

CLINICAL EFFECTS OF COMBINED THERAPY WITH PERITONEAL DIALYSIS AND HEMODIALYSISKAWANISHI, Hideki; MORIISHI, Misaki.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S126-S129, SUP2Conference Paper

GLYCOSAMINOGLYCANS AND PROTEOGLYCANS : OVERLOOKED ENTITIES?YUNG, Susan; TAK MAO CHAN.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S104-S109, SUP2Conference Paper

Mechanisms of antibiotic neurotoxicity in renal failureKAI MING CHOW; SZETO, Cheuk Chun; CHE-FAI HUI, Andrew et al.International journal of antimicrobial agents. 2004, Vol 23, Num 3, pp 213-217, issn 0924-8579, 5 p.Article

CELL THERAPY IN KIDNEY DISEASE : CAUTIOUS OPTIMISM ... BUT OPTIMISM NONETHELESSZENOVICH, Andrey G; TAYLOR, Doris A.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S94-S103, SUP2Conference Paper

PERITONEAL FIBROSIS INTERVENTIONKANEKO, Kayo; HAMADA, Chieko; TOMINO, Yasuhiko et al.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S82-S86, SUP2Conference Paper

THERAPEUTIC OPTIONS FOR PRESERVATION OF RESIDUAL RENAL FUNCTION IN PATIENTS ON PERITONEAL DIALYSISLI, Philip Kamtao; YUK LUN CHENG.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S158-S163, SUP2Conference Paper

WHAT IS THE OPTIMAL FAT MASS IN PERITONEAL DIALYSIS PATIENTS?JOHNSON, David W.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S250-S254, SUP2Conference Paper

ADIPOKINES AND GUT HORMONES IN END-STAGE RENAL DISEASEMAK, Robert H; CHEUNG, Wai.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S298-S302, SUP2Conference Paper

CARDIOVASCULAR RISK FACTORS IN PERITONEAL DIALYSIS PATIENTS REVISITEDWANG, Angela Yee-Moon.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S223-S227, SUP2Conference Paper

ENCAPSULATING PERITONEAL SCLEROSIS : PREVENTION AND TREATMENTKAWANISHI, Hideki; MORIISHI, Misaki.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S289-S292, SUP2Conference Paper

INTRAVENOUS VERSUS ORAL IRON SUPPLEMENTATION IN PERITONEAL DIALYSIS PATIENTSJOHNSON, David W.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S255-S260, SUP2Conference Paper

KEY SUCCESS FACTORS FOR A QUALITY PERITONEAL DIALYSIS PROGRAMNAYAK, K. S.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S9-S15, SUP2Conference Paper

STUDYING THE EFFECTS OF NEW PERITONEAL DIALYSIS SOLUTIONS ON THE PERITONEUMTAK MAO CHAN; YUNG, Susan.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S87-S93, SUP2Conference Paper

SYMPATHETIC HYPERACTIVITY : A HIDDEN ENEMY IN CHRONIC KIDNEY DISEASE PATIENTSBLANKESTIJN, Peter J.Peritoneal dialysis international. 2007, Vol 27, issn 0896-8608, S293-S297, SUP2Conference Paper

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong KongTAM, Lai-Shan; LI, Edmund K; WONG, Shiu-Man et al.Scandinavian journal of rheumatology. 2002, Vol 31, Num 5, pp 296-300, issn 0300-9742, 5 p.Article